Prosaposin is an AR-target gene and its neurotrophic domain upregulates ar expression and activity in prostate stromal cells

Journal of Cellular Biochemistry

Volumn 104, Issue 6, 2008, Pages 2272-2285

  Koochekpour, S ^a,b   Lee, T J ^a   Sun, Y ^c   Hu, S ^a   Grabowski, G A ^c   Liu, Z ^a   Garay, J ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

AR; DHT; Prostate; PSAP; Stromal cells

Indexed keywords

ANDROGEN RECEPTOR; PROSAPOSIN; SPHINGOLIPID ACTIVATOR PROTEIN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FIBROBLAST; GENE TARGETING; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; MALE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; STROMA CELL;

ANDROGENS; ANIMALS; BONE AND BONES; CELL LINE; CELL NUCLEUS; CULTURE MEDIA, CONDITIONED; DIHYDROTESTOSTERONE; FIBROBLASTS; HUMANS; MALE; MICE; NERVE GROWTH FACTORS; PHOSPHOTYROSINE; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANDROGEN; RESPONSE ELEMENTS; SAPOSINS; SERUM; STROMAL CELLS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 49049094837     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21786     Document Type: Article

References (42)

1. Blom N, Gammerltoft S, Brunak S. 1999. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294:1351-1362.
2. Cato AC, Henderson D, Ponta H. 1987. The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region. EMBO J 6:363-368.
3. Cher ML, Towler DA, Rafii S, Rowley D, Donahue H, Keller E, Herlyn M, Cho EA, Chung LWK. 2006. Cancer interaction with bone microenvironment: A workshop of the national institute of health tumor microenvironment study section. Am J Pathol 168:1405-1412.
4. Chung LWK, Gleave ME, Hsieh J-T, Hong S-J, Zhau HE. 1991. Reciprocal mesenchymal-epithelial interaction affecting prostate tumor growth and hormone responsiveness. Cancer Surv 11:91-121.
5. Chung LW, Huang WC, Sung SY, Wu D, Odero-Marah V, Nomura T, Shigemura K, Miyagi T, Seo S, Shi C, Molitierno J, Elmore J, Anderson C, Isotani S, Edlund M, Hsieh CL, Wang R, Shehata B, Zhau HE. 2006. Stromal-epithelial interaction in prostate cancer progression. Clin Genitourin Cancer 5:162-170.
6. Craft N, Shostak Y, Carey M, Sawyers CL. 1999. A mechanism for hormone independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med 5:280-283.
7. Culig Z, Hobisch A, Bartsch G, Klocker H. 2000. Androgen receptor-an update of mechanisms of action in prostate cancer. Urol Res 28:211-219.
8. Ding Y, Yuan H-Q, Kong F, Hu X-Y, Ren K, Cai J, Wang X-L, Young CY. 2007. Ectopic expression of neurotrophic peptide derived from saposin C increases proliferation and upregulates androgen receptor expression and transcriptional activity in human prostate cancer cells. Asian J Androl 9:601-609.
9. Feldman BJ, Feldman D. 2001. The development of androgen-independent prostate cancer. Nat Rev Cancer 1:34-45.
10. Gioeli D, Ficarro SB, Kwiek JJ, Aaronson D, Hancock M, Catling AD, White FM, Christian RE, Settlage RE, Shabanowitz J, Hunt DF, Weber MJ. 2002. Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J Biol Chem 277:29304-29314.
11. Ham J, Thomson A, Needham M, Webb P, Parker M. 1988. Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumor virus. Nucleic Acids Res 24:5263-5276.
12. Henseler M, Klein A, Glombitza GJ, Suziki K, Sandhoff K. 1996. Expression of the three alternative forms of the sphingolipid activator protein precursor in baby hamster kidney cells and functional assays in a cell culture system. J Biol Chem 271:8416-8423.
13. Huwiler A, Kolter T, Pfeilschifter J, Sandhoff K. 2000. Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta 485:63-99.
14. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. 2007. Cancer statistics. CA Cancer J Clin 57:43-66.
15. Johansson A, Rudolfsson SH, Wilkstroom P, Bergh A. 2005. Altered level of angiopoietin 1 and tie 2 are associated with androgen-regulated vascular regression and growth in the ventral prostate in adult mice and rats. Endocrinology 146:3463-3469.
16. Kishimoto Y, Hiraiwa M, O'Brien JS. 1992. Saposins: Structure, function, distribution and molecular genetics. J Lipid Res 33:1255-1267.
17. Koochekpour S. 2006. PSAP (Prosaposin (variant Gaucher disease and variant metachromatic leukodystrophy)). Atlas Genet Cytogenet Oncol Haematol. URL: http://www.infobiogen.fr/services/chromcancer/Genes/PSA-PID42980ch10q22. html.
18. Koochekpour S, Jeffers M, Wang PH, Gong C, Taylor GA, Roessler LM, Stearman R, Vasselli JR, Stetler-Stevenson WG, Kaelin WG, Jr., Linehan WM, Klausner RD, Gnarra JR, Vande Woude GF. 1999. The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol Cell Biol 19:5902-5912.
19. Koochekpour S, Maresh A, Katner A, Parker-Johnson K, Lee TJ, Hebert FE, Kao YS, Skinner J, Rayford W. 2004a. Establishment and characterization of a primary androgen-responsive African-American prostate cancer cell line, E006AA. Prostate 60:141-152.
20. Koochekpour S, Sartor O, Lee TJ, Zieske AJ, Patten DY, Hiraiwa M, Sandhoff K, Remmel N, Minokadeh A. 2004b. Prosaptide TX14A stimulates growth, migration, and invasion and activates the Raf-MEK-ERK-RSK-Elk-1 signaling pathway in prostate cancer cells. Prostate 61:114-123.
21. Koochekpour S, Sartor O, Hiraiwa M, Lee TJ, Rayford W, Remmel N, Sandhoff K, Minokadeh A, Patten DY. 2005a. Saposin C stimulates growth and invasion, activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells. Asian J Androl 7:147-158.
22. Koochekpour S, Zhuang YJ, Beroukhim R, Hsieh CL, Hofer MD, Zhau HE, Hiraiwa M, Pattan DY, Ware JL, Luftig RB, Sandhoff K, Sawyers CL, Pienta KJ. 2005b. Amplification and overexpression of prosaposin in prostate cancer. Genes Chromosomes Cancer 44:351-364.
23. Koochekpour S, Lee TJ, Wang R, Culig Z, Delorme N, Caffey S, Marrero L, Aguirre J. 2007a. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Prostate 67:178-189.
24. Koochekpour S, Lee TJ, Wang R, Sun Y, Delorme N, Hiraiwa M, Grabowski GA, Culig Z, Minokadeh A. 2007b. Prosaposin is a novel androgen-regulated gene in prostate cancer cell line LNCaP. J Cell Biochem 101:631-641.
25. Kraus S, Gioeli D, Vomastek T, Gordon V, Weber MJ. 2006. Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor. Cancer Res 66:11047-11054.
26. Kuiper GG, Brinkmann AO. 1995. Phosphotryptic peptide analysis of the human androgen receptor: Detection of a hormone-induced phosphopeptide. Biochemistry 34:1851-1857.
27. Kurita T, Wang Y, Dahiya R, Cunha GR. 2001. Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive systems. Cell Death Differ 8:192-200.
28. Lee TJ, Sartor O, Luftig R, Koochekpour S. 2004. Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells. Mol Cancer 3:31.
29. Morales CR, Zhao Q, El-Alfy M, Suzuki K. 2000. Targeted disruption of the mouse prosaposin gene affects the development of the prostate gland and other male reproductive organs. J Androl 21:765-775.
30. Morin B, Zhu C, Woodcock GR. 2000. The binding site for Xenopus glucocorticoid receptor accessory factor and a single adjacent half-GRE form an independent glucocorticoid response unit. Biochemistry 39:12234-12242.
31. Morrissey C, Vessella RL. 2007. The role of tumor microenvironment in prostate cancer bone metastasis. J Cell Biochem 101:873-886.
32. O'Malley BW, Tsai SY, Bagchi M, Weigel NL, Schrader WT, Tsai MJ. 1991. Molecular mechanism of action of a steroid hormone receptor. Recent Prog Horm Res 47:1-24.
33. Ohlson N, Bergh A, Stattin P, Wilkstrom P. 2007. Castration-induced epithelial cell death in human prostate tissue is related to locally reduced IGF-1 levels. Prostate 67:32-40.
34. Parker MG, Webb P, Mills JS, Needham M, White R. 1988. Analysis of regulatory sequences in androgen-responsive genes. J Steroid Biochem 30:47-51.
35. Sandhoff K, Kolter T. 2003. Biosynthesis and degradation of mammalian glycosphingolipids. Philos Trans R Soc Lond B Biol Sci 358:847-861. Review
36. Simon AM, Veyssiere G, Jean C. 1995. Structure and sequence of a mouse gene encoding an androgen-regulated protein: A new member of the seminal vesicle secretory protein family. J Mol Endocrinol 15:305-306.
37. Strahle U, Klock G, Schultz GA. 1987. A DNA sequence of 15 base pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression. Proc Natl Acad Sci USA 84:7871-7875.
38. Sun Y, Jin P, Witte DP, Grabowski GA. 1998. Isolation and characterization of the human prosaposin promoter. Gene 218:37-47.
39. Sung SY, Hsieh CL, Wu D, Chung LW, Johnstone PA. 2007. Tumor microenvironment promotes cancer progression, metastasis, and therapeutic resistance. Curr Probl Cancer 31:36-100. Review
40. Vessella RL, Corey E. 2006. Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis. Clin Cancer Res 12:6285s-6290s.
41. Wikstrom P, Phlson N, Stattin P, Bergh A. 2007. Nuclear androgen receptors recur in the epithelial and stromal compartment of malignant and non-malignant human prostate tissue several months after castration therapy. Prostate 67:1274-1288.
42. Yeung F, Li X, Ellett J, Trapman J, Kao C, Chung LW. 2000. Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells. J Biol Chem 275:40846-40855.